Загрузка...
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
One of the last remaining clinical hurdles in the treatment of people with hemophilia is the development of inhibitors. Alloantibodies or autoantibodies directed at coagulation factors render the infusion of coagulation factor concentrates ineffective, and alternative means must be used to achieve h...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2915537/ https://ncbi.nlm.nih.gov/pubmed/20689699 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|